IPPOLITO, EDY
 Distribuzione geografica
Continente #
AS - Asia 5.759
NA - Nord America 601
EU - Europa 481
SA - Sud America 17
AF - Africa 15
OC - Oceania 4
Totale 6.877
Nazione #
SG - Singapore 5.247
US - Stati Uniti d'America 564
CN - Cina 319
IT - Italia 151
HK - Hong Kong 133
DE - Germania 79
GB - Regno Unito 67
NL - Olanda 49
EE - Estonia 33
FI - Finlandia 29
CA - Canada 22
BR - Brasile 14
MX - Messico 14
IN - India 13
TR - Turchia 11
UA - Ucraina 11
CZ - Repubblica Ceca 10
ZA - Sudafrica 10
FR - Francia 9
ID - Indonesia 9
ES - Italia 8
RO - Romania 8
AT - Austria 6
BD - Bangladesh 6
PL - Polonia 6
SE - Svezia 5
AU - Australia 4
JP - Giappone 4
VN - Vietnam 3
AR - Argentina 2
BG - Bulgaria 2
IL - Israele 2
LT - Lituania 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DK - Danimarca 1
GN - Guinea 1
GP - Guadalupe 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
ME - Montenegro 1
ML - Mali 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TJ - Tagikistan 1
TL - Timor Orientale 1
UZ - Uzbekistan 1
Totale 6.877
Città #
Singapore 201
Hefei 182
Hong Kong 129
Ashburn 113
Dallas 94
Rome 70
Munich 62
Boardman 61
Beijing 59
Shanghai 56
London 53
Amsterdam 40
Los Angeles 25
Council Bluffs 19
Milan 16
Helsinki 15
Turku 14
Brooklyn 13
Toronto 13
Mexico City 12
Washington 12
New York 11
San Francisco 11
Santa Clara 9
Brno 8
Seattle 8
West Jordan 8
Ankara 7
Boston 7
São Paulo 7
Pune 6
Redmond 6
Sona 6
Atlanta 5
Chicago 5
Rocca di Papa 5
Stockholm 5
Warsaw 5
Johannesburg 4
Vicenza 4
Bologna 3
Capaccio 3
Charlotte 3
Guangzhou 3
Montesilvano Marina 3
Naples 3
Osimo 3
Vienna 3
Bangalore 2
Banqiao 2
Bucharest 2
Buffalo 2
Central 2
Chennai 2
Cincinnati 2
City of London 2
Cleveland 2
Denver 2
Hanover 2
Harbin 2
Ho Chi Minh City 2
Jakarta 2
Lyon 2
New Delhi 2
Nuremberg 2
Olomouc 2
Palermo 2
Pescara 2
Phoenix 2
Quarrata 2
Sant'Anastasia 2
Shijiazhuang 2
Southall 2
Sydney 2
Temecula 2
Tokyo 2
Vancouver 2
Xi'an 2
Aarhus 1
Andover 1
Baie-Mahault 1
Bamako 1
Barcelona 1
Basra 1
Bismarck 1
Bratislava 1
Buenos Aires 1
Calgary 1
Camden 1
Cameri 1
Can Tho 1
Canberra 1
Caracal 1
Centurion 1
Charleston 1
Chengdu 1
Clifton 1
Conakry 1
Concord 1
Criciúma 1
Totale 1.492
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 257
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 235
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 203
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 196
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 196
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 195
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 189
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 188
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 188
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer 187
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 186
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 184
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 184
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 181
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I–II study (ADA-RT-1) 181
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 180
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study 176
Lymph nodal radiotherapy in breast cancer: what are the unresolved issues? 170
Preventing Cardiotoxicity in Personalized Breast Irradiation 170
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 170
Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform 169
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 121
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 106
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 103
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 102
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 100
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 99
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 96
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 95
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 95
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 94
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 94
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 92
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 92
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 91
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 91
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 88
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 87
Daily on-line set-up correction in 3D-conformal radiotherapy: Is it feasible? 82
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 67
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 66
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 65
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 61
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study 60
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 59
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 55
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 50
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 33
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 29
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 25
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 24
PO-0672 Ten years experience of breast reconstruction after mastectomy in previously irradiated patients 22
SBRT: A viable option for treating adrenal gland metastases 22
Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature 22
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach 21
Radiotherapy in breast cancer with voluntary deep- inspiration breath-hold using BrainLab Exactrac 21
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 21
Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment 21
Precision radiotherapy by SPECT lung functional imaging in NSCLC 21
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 20
Stereotactic body radiation therapy for early stage NSCLC: clinical outcomes 20
PV-0276 Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC. 20
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 20
Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group 18
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study † 18
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 18
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. 18
The role of mammography after breast-conserving surgery and adjuvant chemotherapy 18
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 17
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 17
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 16
IGRT in rectal cancer 16
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/ RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups 15
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion preliminary report on toxicity 15
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 15
Occult mediastinal node involvement in non-small cell lung cancer after negative uptake on PET/CT: Ripples through staging and therapy. Case report and critical review 15
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 15
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 15
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: A case series 15
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1) 14
External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study 13
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups 13
Predictive factors of late-onset rectal mucosal changes after radiotherapy of prostate cancer 13
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 13
Postoperative Intensity Modulated Radiation Therapy in High Risk Prostate Cancer: A Dosimetric Comparison 12
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 11
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 11
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: A phase I study 11
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 11
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 10
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 8
Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups 7
Totale 6.966
Categoria #
all - tutte 28.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 2 4 3 2 1 3 10 3 0 56
2022/202341 0 1 0 2 1 1 4 13 3 0 12 4
2023/2024231 8 19 15 11 17 82 13 11 3 17 10 25
2024/20256.064 41 20 121 63 38 103 78 27 227 384 2.316 2.646
2025/2026546 286 176 84 0 0 0 0 0 0 0 0 0
Totale 6.966